The cash and debt free consideration value is €370 million.
Sun Pharma discontinue development of SCD-044 drug after trial disappointment
Bristol Myers Squibb and BioNTech sign up to $11 billion cancer bispecific antibody collaboration
Allarity announces enrolment of first patient in phase 2 clinical trial protocol of Stenoparib in advanced ovarian cancer
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes